…, Pachter L, Forman SJ, Priceman SJ. PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat Med. 2024 Jun;30(6):1636-1644.Kostopoulos…
5articles mentioning diseases
6disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Metastatic castration-resistant prostate cancer (mCRPC)
This disease is selected. Its supporting articles are shown below.
Articles mentioning Metastatic castration-resistant prostate cancer (mCRPC)
5 articles · page 1 of 1metastatic castration-resistant prostate cancermetastatic castration-resistant prostate cancer (mCRPC)mCRPC177Lu-PSMA-617cyclophosphamideCyRPTNCT03873805
Metastatic castration-resistant prostate cancer (mCRPC)mCRPColaparibSTAR0602mSTAR1302mSTAR1302-mediatedNCT05592626
…Background Metastatic castration-resistant prostate cancer (mCRPC) remains an aggressive disease with limited response to systemic…
Metastatic castration-resistant prostate cancer (mCRPC)mCRPCAB-3028
…Background Metastatic castration-resistant prostate cancer (mCRPC) remains a disease with low long-term survival, and while new mo…
Metastatic castration-resistant prostate cancer (mCRPC)mCRPCchimeric antigen receptor (CAR) T cell therapydnTGFβRIISTEAP2
…Background Metastatic castration-resistant prostate cancer (mCRPC) is a lethal, treatment-refractory stage of disease, frequently …
86.5%
mCRPCsolid tumorshematological malignanciesmetastatic castration-resistant prostate cancer (mCRPC)prostate tumorsAB-3028TCGAThe Cancer Genome AtlasGTExChimeric Antigen Receptor T (CAR T) cell therapies
…ns These collective data support the development of AB-3028 for mCRPC.…